|
ORASURE TECHNOLOGIES TO COMMEMORATE WORLD AIDS DAY BY RINGING NASDAQ CLOSING BELL
BETHLEHEM, Pa., Nov. 30, 2020 (GLOBE NEWSWIRE) - OraSure Technologies , Inc., (NASDAQ: OSUR), a leader in the fight against HIV, today announced its plans to commemorate World AIDS Day. On Tuesday, Dec. 1st, OraSure will ring the closing bell for the NASDAQ Stock Market, in a virtual ceremony that will be livestreamed.
“A year ago, on World AIDS Day 2019, it appeared that eliminating the HIV epidemic was within our grasp. Today, we’re in a far different place as COVID-19 has disrupted the delivery of testing, services and care, reversing many of the gains we’ve made,” said OraSure President and CEO, Stephen S. Tang, Ph.D. “Today, on World AIDS Day 2020, it’s time to put a stake in the ground: We cannot let the HIV epidemic take a back seat to COVID-19. At OraSure, we are proud of the ways in which we are meeting the global need for HIV diagnostics, and we are committed to doing the same for COVID-19.”
To commemorate World AIDS Day globally, OraSure also partnered with the MTV Staying Alive Foundation on a video campaign, based around an African television series MTV Shuga, which encourages young adults to take an HIV self-test. Furthermore, in Kenya, the Ministry of Health has partnered with OraSure to pilot electronic vending machines for HIV self-test kits. The machines will launch on World AIDS Day. The widely used OraQuick® HIV Self-Test was the first WHO-prequalified HIV self-test in Sub-Saharan Africa.
###
About OraSure Technologies
OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. Together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, CoreBiome (now operating under the Diversigen brand), UrSure and Novosanis, OraSure provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com.
MEDIA CONTACT:
Sam Martin
Argot Partners
212-600-1902
OraSure@argotpartners.com
Jeanne Mell
VP Corporate Communications
484-353-1575
media@orasure.com
www.orasure.com
Source: OraSure Technologies, Inc.
"Reproduced with permission - OraSure Technologies, Inc."
OraSure Technologies, Inc.
For more HIV and AIDS News visit...
Positively Positive - Living with HIV/AIDS:
HIV/AIDS News
|
